Molecule Details
| InChIKey | LUZRJRNZXALNLM-JGRZULCMSA-N |
|---|---|
| Compound Name | Dihydroergotamine |
| Canonical SMILES | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 20 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.59 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00320 |
|---|---|
| Drug Name | Dihydroergotamine |
| CAS Number | 511-12-6 |
| Groups | approved |
| ATC Codes | N02CA51 N02CA01 |
| Description | A 9,10alpha-dihydro derivative of [ergotamine]. Dihydroergotamine is used as an abortive therapy for migraines.[L38469] Its use has largely been supplanted by triptans in current therapy due to the class's greater selectivity and more favourable side effect profile. Recent improvements have been mad... |
Categories: Adrenergic Antagonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Agents that produce hypertension Alkaloids Analgesics Antidepressive Agents Antimigraine Preparations Cardiovascular Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dopamine Agents Dopamine Agonists Ergot Alkaloids and Derivatives Ergot-derivative Dopamine Receptor Agonists Ergotamine Derivative Ergotamines Heterocyclic Compounds, Fused-Ring Narrow Therapeutic Index Drugs Nervous System Neurotransmitter Agents P-glycoprotein inhibitors Peripheral Nervous System Agents Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT1 Receptor Agonists Serotonin 5-HT2 Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists Sympatholytic (Adrenergic Blocking) Agents Vasoconstrictor Agents
Cross-references: BindingDB: 50295557 ChEBI: 4562 CHEMBL1732 ChemSpider: 10091 Drugs Product Database (DPD): 3359 C07798 D07837 PDB: 2GM PharmGKB: PA164743028 PubChem:10531 PubChem:46507711 RxCUI: 3418 Therapeutic Targets Database: DAP000078 Wikipedia: Dihydroergotamine ZINC: ZINC000003978005
Target Activities (20)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P08913 | ADRA2A | Homo sapiens | Human | PF00001 | 9.0 | Ki | ChEMBL |
| P50406 | HTR6 | Homo sapiens | Human | PF00001 | 8.5 | Ki | ChEMBL |
| P18089 | ADRA2B | Homo sapiens | Human | PF00001 | 8.4 | Ki | ChEMBL |
| P41595 | HTR2B | Homo sapiens | Human | PF00001 | 8.4 | Ki | ChEMBL |
| P35462 | DRD3 | Homo sapiens | Human | PF00001 | 8.3 | Ki | ChEMBL |
| P28223 | HTR2A | Homo sapiens | Human | PF00001 | 8.1 | Ki | ChEMBL |
| P14416 | DRD2 | Homo sapiens | Human | PF00001 | 8.1 | Ki | ChEMBL |
| P18825 | ADRA2C | Homo sapiens | Human | PF00001 | 8.0 | Ki | ChEMBL |
| P25100 | ADRA1D | Homo sapiens | Human | PF00001 | 7.5 | IC50 | ChEMBL |
| P35348 | ADRA1A | Homo sapiens | Human | PF00001 | 7.5 | Kd | ChEMBL |
| P47898 | HTR5A | Homo sapiens | Human | PF00001 | 7.5 | Ki | ChEMBL |
| P21917 | DRD4 | Homo sapiens | Human | PF00001 | 7.5 | Ki | ChEMBL |
| P08908 | HTR1A | Homo sapiens | Human | PF00001 | 7.4 | Ki | ChEMBL |
| P35368 | ADRA1B | Homo sapiens | Human | PF00001 | 7.2 | Kd | ChEMBL |
| P34969 | HTR7 | Homo sapiens | Human | PF00001 | 7.2 | Ki | ChEMBL |
| P28335 | HTR2C | Homo sapiens | Human | PF00001 | 7.0 | Ki | ChEMBL |
| P28222 | HTR1B | Homo sapiens | Human | PF00001 | 7.0 | Ki | ChEMBL |
| P35372 | OPRM1 | Homo sapiens | Human | PF00001 | 6.8 | Ki | ChEMBL |
| Q99720 | SIGMAR1 | Homo sapiens | Human | PF04622 | 6.2 | Ki | ChEMBL |
| P28566 | HTR1E | Homo sapiens | Human | PF00001 | 6.2 | Ki | ChEMBL |
DrugBank Target Actions (18)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P08908 | HTR1A | 5-hydroxytryptamine receptor 1A | agonist | targets |
| P08913 | ADRA2A | Alpha-2A adrenergic receptor | agonist | targets |
| P13945 | ADRB3 | Beta-3 adrenergic receptor | agonist | targets |
| P14416 | DRD2 | D(2) dopamine receptor | agonist | targets |
| P21917 | DRD4 | D(4) dopamine receptor | agonist | targets |
| P28221 | HTR1D | 5-hydroxytryptamine receptor 1D | agonist | targets |
| P28222 | HTR1B | 5-hydroxytryptamine receptor 1B | agonist | targets |
| P28223 | HTR2A | 5-hydroxytryptamine receptor 2A | agonist | targets |
| P28335 | HTR2C | 5-hydroxytryptamine receptor 2C | agonist | targets |
| P28566 | HTR1E | 5-hydroxytryptamine receptor 1E | agonist | targets |
| P30939 | HTR1F | 5-hydroxytryptamine receptor 1F | agonist | targets |
| P35348 | ADRA1A | Alpha-1 adrenergic receptors | agonist | targets |
| P35462 | DRD3 | D(3) dopamine receptor | agonist | targets |
| P41595 | HTR2B | 5-hydroxytryptamine receptor 2B | agonist | targets |
| Q13639 | HTR4 | 5-hydroxytryptamine receptor 4 | agonist | targets |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | inhibitor | transporters |